Headache

Upcoming treatments for migraine: zavegepant, rimegepant and atogepant 3:02
Upcoming treatments for migraine: zavegepant, rimegepant and atogepant
Jessica Ailani • 18 Apr 2021
Comprehensive migraine update at AAN 2021 2:18
Comprehensive migraine update at AAN 2021
Jessica Ailani • 18 Apr 2021
The importance of shared decision making in migraine 4:04
The importance of shared decision making in migraine
Jessica Ailani • 18 Apr 2021
The unmet needs of migraine patients 1:25
The unmet needs of migraine patients
Jessica Ailani • 26 Oct 2020
Long-term intermittent use of ubrogepant to treat acute migraines 5:26
Long-term intermittent use of ubrogepant to treat acute migraines
Jessica Ailani • 26 Oct 2020
Therapeutic landscape for cluster headache 11:31
Therapeutic landscape for cluster headache
Stewart Tepper • 24 May 2020
Challenges in migraine management 2:09
Challenges in migraine management
Uwe Reuter • 22 May 2020
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic 20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper • 24 May 2020
BKCa channels: potential novel anti-migraine target 4:14
BKCa channels: potential novel anti-migraine target
Messoud Ashina • 29 May 2020
Benefit of migraine prevention with erenumab 19:11
Benefit of migraine prevention with erenumab
Stewart Tepper • 24 May 2020
The evolving landscape of migraine treatment and prevention 3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter • 22 May 2020
PROMISE-1: eptinezumab in episodic migraine 2:44
PROMISE-1: eptinezumab in episodic migraine
Messoud Ashina • 29 May 2020
Understanding migraines better with AI 0:58
Understanding migraines better with AI
Dagny Holle-Lee • 20 May 2020
Fremanezumab in patients with chronic or episodic migraine 2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter • 22 May 2020
CONQUER: galcanezumab in treatment-resistant migraine 9:29
CONQUER: galcanezumab in treatment-resistant migraine
Stewart Tepper • 24 May 2020
HER-MES study: erenumab versus topiramate in episodic migraine 2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter • 22 May 2020
The content of VJNeurology is intended for healthcare professionals